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Introduction {#sec005}
============

Bee venom is one of the most commonly encountered animal venoms and consists of various chemical agents that induce allergic reactions in the human body \[[@pone.0126971.ref001]\]. Bee venom therapy (BVT), in which bee venom is used for medicinal purposes, is available worldwide, but is primarily utilized in Asia, Eastern Europe, and South America \[[@pone.0126971.ref002]\]. The diverse therapeutic applications of BVT include various musculoskeletal conditions, such as arthritis and rheumatism, chronic recalcitrant neuralgia, arthralgia, and immune-related diseases. BVT is also used to desensitize patients to bee stings and thus inhibit allergic reactions \[[@pone.0126971.ref003]\] \[[@pone.0126971.ref004]\] \[[@pone.0126971.ref005]\].

Although the therapeutic utility of bee venom has been demonstrated, its safety profile is an important limiting consideration, because immune responses to BVT can range from trivial skin reactions that resolve over several days to life-threatening responses such as anaphylaxis \[[@pone.0126971.ref006]\] \[[@pone.0126971.ref007]\]. In a recent survey, the incidence of systematic reactions (SRs) in patients who received venom and inhaled-allergen subcutaneous immunotherapy was 13.60%, whereas the prevalence of SRs in patients that received bee venom immunotherapy (VIT) was 28.72% \[[@pone.0126971.ref008]\]. In another survey, 12.13% patients who received VIT experienced SRs (an average of 1.91 SR events per subject), suggesting that serious adverse events (SAEs) due to BVT are quite common \[[@pone.0126971.ref009]\].

The most significant issue related to the AEs of BVT is that the occurrence of SAEs is unpredictable. It is therefore necessary to determine the prevalence and nature of AEs related to various types of BVT, so that bee venom can be used safely in clinical practice. The aim of this systematic review was to provide summary information regarding the types of AEs related to BVT and their prevalence in treated patients.

Methods {#sec006}
=======

Study selection {#sec007}
---------------

### Types of studies {#sec008}

All types of clinical studies, including randomized controlled trials (RCTs) and randomized crossover trials, as well as observational studies, including cohort studies, case-control studies, case series, and case studies, were included in this study.

### Types of participants {#sec009}

The subjects of the studies evaluated in this review included adults and pediatric patients, and the selection was not limited to studies of patients with specific diseases. Regardless of a patient's condition and disease status, studies were included if bee venom was used as a key intervention, and AEs that may have been causally related to BVT were reported.

### Types of interventions {#sec010}

In this review, we included studies of bee sting acupuncture (BSA), a subcutaneous or intramuscular injection of bee venom for the purpose of acupoint stimulation (bee venom acupuncture \[BVA\], sweet bee venom \[SBV\]), and dried honeybee venom (apitoxin injections), as well as subcutaneous VIT for desensitization of venom immune reactions. BSA, BVA, SBV, and apitoxin injections usually involve the use of venom derived from bees (family Apidae), whereas VIT generally involves the use of venom from bees (family Apidae) and wasps (family Vespidae) concomitantly. Therefore, we included all types of venom therapy including both bee and wasp venoms. We also reviewed studies where bee venom was used alone or in combination with other treatments. However, studies describing bee stings resulting from random encounters (e.g., during resting or by attack), sting challenge tests, sublingual VIT, and irrelevant venom types were excluded from this study. We included RCTs comparing BVT with no treatment, normal saline injections, and conventional medications for relative risk assessment. Trials in which different types of BVT were compared with each other were excluded.

### Types of outcome measures {#sec011}

The major aim of this review was to identify the frequency and types of AEs related to BVT. In case studies and case review series, the type of AE was classified into 1 of 3 categories: SR, skin problem (SP), and other (nonspecific reaction, symptom, or sign that was not an SR or SP). If an SR occurred as an AE, it was classified into 1 of 5 categories based on the Mueller classification (grade I, grade II, grade III, and grade IV) \[[@pone.0126971.ref010]\]. The causal relationship between BVT and AEs was also assessed in each study according to the WHO-UMC causality scale \[[@pone.0126971.ref011]\]. AEs were scored as certain when they clearly occurred after BVT, disappeared after withdrawal, and could not be explained by other diseases or treatments. AEs were scored as probable when the timing of the AEs and BVT indicated that they were most likely related, they disappeared as a probable result of the discontinuation of BVT, and the events were not induced by other diseases or treatment. AEs were scored as possible when they occurred after BVT treatment but no information was available on the relationship between their disappearance and the withdrawal of BVT and when they could potentially be explained by other diseases or treatments. In addition, AEs were scored as unlikely when the event and the BVT had an improbable causal relationship. AEs were scored as conditional/unclassified when the event occurred but more data were necessary for a conclusion to be reached. Finally, AEs were scored as unassessable/unclassifiable when they could not be evaluated properly owing to insufficient and/or contradictory information \[[@pone.0126971.ref012]\].

In audits and cohort studies, AE types were divided into SR, large local reaction (LLR), local reaction (LR), and other (nonspecific reaction, symptom, or sign that was not an SR, LLR, or LR). An LLR was defined as swelling exceeding 10 cm in diameter and lasting longer than 24 h, and an LR was defined as local pruritus, edema, or erythema \[[@pone.0126971.ref013]\]. Finally, the prevalence of AEs related to BVT was assessed through observational studies, including audits and cohort studies.

Data sources {#sec012}
------------

The following 12 databases were searched: PubMed, EMBASE, the Cochrane Library, CINAHL, China National Knowledge Infrastructure (CNKI), Wanfang (China), Weipu (China), KoreaMED, the Korean Medical Database (KMBASE), the Korean Studies Information Service System (KISS), National Discovery for Science Leaders (NDSL) (Korea), and the Oriental Medicine Advanced Searching Integrated System (OASIS) (Korea). Bibliographic references in relevant publications (Journal of Pharmacopuncture) were manually searched to avoid missing eligible articles. The References sections of reviews on AEs of BVT were searched manually, and articles published through June 2014 were included. The search terms consisted of two parts: "BVT" (e.g., bee sting, apitoxin, or venom immunotherapy) and "adverse events" (e.g., adverse reaction, side effects, risk, or safe). The search strategy was modified appropriately according to the databases. The detailed search strategies for PubMed, China National Knowledge Infrastructure (CNKI), Wanfang (China), Weipu (China), KoreaMED, the Korean Medical Database (KMBASE), the Korean Studies Information Service System (KISS), National Discovery for Science Leaders (NDSL) (Korea), and the Oriental Medicine Advanced Searching Integrated System (OASIS) (Korea) are presented in the Supporting Information.

Data collection and analysis {#sec013}
----------------------------

### Study selection {#sec014}

Two independent reviewers (JHP and BKY) screened the articles for inclusion by title and abstract. If disagreements regarding the selection of a study could not be resolved through discussion, the final decision was made by the arbiter (THK).

### Data extraction and management {#sec015}

One reviewer (JHP) read the full text of the articles selected for review and extracted the data using a standard data extraction form. Another reviewer (BKY) rechecked the data to ensure that it had been extracted appropriately. Any disagreement among the reviewers was resolved by discussion or by the arbiter (THK).

### Quality assessment of AEs in RCTs {#sec016}

To evaluate the quality of the detection and reporting of the AEs in the included RCTs, 7 items were assessed according to the CONSORT recommendations for harm data: (1) mention of AEs in the title or abstract, (2) mention of BVT-related AEs in the introduction, (3) predefined definition of AEs related to BVT, (4) collection or monitoring method for AEs, (5) mention of the method for analyzing and presenting AEs, (6) mention of any patients who dropped out of the study owing to AEs, and (7) mention of the specific denominator for the analysis of AEs \[[@pone.0126971.ref014]\] \[[@pone.0126971.ref015]\]. The quality of each item was judged as good, moderate, bad, or not reported \[[@pone.0126971.ref012]\]. The quality of a study was scored as good if each item was reported clearly in the manuscript or in the registered protocol. If each item was reported, but not in detail, the methodological quality was scored as moderate. The quality of a study was scored as bad when any of the items were not appropriately reported. If an item was not described at all, it was recorded as not reported.

Statistical analysis {#sec017}
--------------------

A meta-analysis of the RCTs was conducted if the incidence of AEs was clearly reported and the relative risk of AEs could be assessed because of similar study designs and intervention methods, including BVT types and control interventions, with minimal clinical heterogeneity. The relative risk of BVT and control interventions was assessed, and effects were calculated using Revman 5.2 software (<http://ims.cochrane.org/revman>).

Results {#sec018}
=======

Through electronic and manual searching, 8,108 potentially relevant articles were identified, including 5,504 records from PubMed, EMBASE, the Cochrane Library, and CINAHL; 468 records from the Chinese databases; and 2,136 records from the Korean databases, from which 2,118 duplicate records were removed. Through a screening process involving the use of the titles and abstracts of identified records, we excluded 5,699 records that did not meet the inclusion criteria. The remaining 291 articles were reviewed for eligibility, and 146 articles were excluded, including experimental studies (32), reviews (57), surveys (3), studies without description of the assessment of AEs (43), and studies without relevant intervention or comparison groups (11). Finally, 145 studies, including 20 RCTs, 79 audits and cohort studies, 33 single-case studies, and 13 case series, were included in the review ([Fig 1](#pone.0126971.g001){ref-type="fig"}).

![Flow diagram of the study selection process.](pone.0126971.g001){#pone.0126971.g001}

Case studies and case series {#sec019}
----------------------------

Thirty-three single-case studies and 13 case series were identified as described in [Table 1](#pone.0126971.t001){ref-type="table"} \[[@pone.0126971.ref002],[@pone.0126971.ref007],[@pone.0126971.ref016]--[@pone.0126971.ref059]\]. A total of 69 individual isolated cases were reported in 46 papers. Incidents were reported in 11 countries: Korea (37 cases), China (10 cases), the United States (7 cases), France (6 cases), Germany (2 cases), Turkey (2 cases), Canada (1 case), Italy (1 case), Russia (1 case), Saudi Arabia (1 case), and the Slovak Republic (1 case). The reported BVT methods included BSA (29), BVA (21), and VIT (19). Among the 69 AE cases, 58 cases were related to BVT, 6 cases were related to wasp venom treatment, and 5 cases were related to treatment with a mixture of bee venom and wasp venom. Among the 58 AE cases related to treatment with bee venom only, 30 SRs, 23 SPs, and 5 other cases, including cough; headache; uremia; anorexia; discoloration of the sclera; jaundice; painful cyclic uterine contractions; severe pain affecting the left shoulder, chest wall, and left arm; and muscular weakness in the left arm and hand, were reported. The 30 SRs related to treatment with bee venom only were classified as grade I (5 cases), grade II (10 cases), grade III (14 cases), and grade IV (1 case). The severity of the AEs related to BVT only were reported as moderate (34 cases) or severe (24 cases), and the causality was deemed to be probable for 49 cases and possible for 9 cases. Most practitioners were qualified practitioners (30 cases), and 4 patients were treated by unqualified personal with no medical training or licensure regarding BSA. One patient died after treatment by an unqualified BSA practitioner. In 23 cases, there was no description of the practitioner. A pre-treatment skin test for venom allergies was reported in only 10 cases, and it was almost always performed prior to VIT, whereas in most cases of BSA and BVA, it was not reported whether or not this test was conducted.

10.1371/journal.pone.0126971.t001

###### Case studies and case series on adverse events associated with bee venom therapy.

![](pone.0126971.t001){#pone.0126971.t001g}

  Study (first author, year)                                        Country           Number of cases   Reason for BVT                                 Practitioner type                          BVT stimulation feature        Venom type[^a^](#t001fn002){ref-type="table-fn"}   Skin test               Injection amount                                      Concomitant treatment                                                  AE symptoms                                                                                                                                                                                      AE severity[^b^](#t001fn003){ref-type="table-fn"}   AE type[^c^](#t001fn004){ref-type="table-fn"}   Mueller classification[^d^](#t001fn005){ref-type="table-fn"}   Diagnosis                                                      Causality[^e^](#t001fn006){ref-type="table-fn"}
  ----------------------------------------------------------------- ----------------- ----------------- ---------------------------------------------- ------------------------------------------ ------------------------------ -------------------------------------------------- ----------------------- ----------------------------------------------------- ---------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ --------------------------------------------------- ----------------------------------------------- -------------------------------------------------------------- -------------------------------------------------------------- -------------------------------------------------
  **Bee sting acupuncture (BSA) and bee venom acupuncture (BVA)**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
  Alqutub 2011 \[[@pone.0126971.ref002]\]                           Saudi Arabia      1 case (F/35)     Multiple sclerosis                             Local practitioner                         BSA                            Bees                                               Not reported            10 bee stings                                         Not reported                                                           Fatigue, anorexia, and discoloration of sclera (jaundice)                                                                                                                                        Severe                                              Others                                          \-                                                             Hepatotoxicity                                                 Probable
  An 2001 \[[@pone.0126971.ref016]\]                                Korea             3 cases a) F/58   a\) Degenerative knee arthritis                a\) KMD                                    a\) BVA                        Bees                                               a\) Not reported        a\) BV injection 2,000:1, 0.35 mL                     a\) Cold pack                                                          a\) Extreme pain, muscular convulsion and tremble, ocular hyperemia, sleepiness, stiffness of limbs, and hyperventilation                                                                        a\) Severe                                          a\) SR                                          a\) Grade III                                                  a\) Pain shock                                                 a\) Probable
                                                                                      b\) F/57          b\) Progressive bulbar paralysis               b\) KMD                                    b\) BVA                        Bees                                               b\) Not reported        b\) BV injection 2,000:1, 0.1 mL                      b\) Cold pack, acupuncture, pharmacopuncture                           b\) Extreme pain, facial sweating, asthenia of limbs, pallor face, weak voice, and sleepiness                                                                                                    b\) Severe                                          b\) SR                                          b\) Grade III                                                  b\) Pain shock                                                 b\) Probable
                                                                                      c\) F/54          c\) Amyotropic lateral sclerosis               b\) KMD                                    c\) BVA                        Bees                                               c\) Not reported        c\) BV injection 2,000:1, 0.3 mL                      c\) Cold pack                                                          c\) Extreme pain, facial sweating, asthenia of limbs, pallor face, weak voice, and sleepiness                                                                                                    c\) Severe                                          c\) SR                                          c\) Grade III                                                  c\) Pain shock                                                 c\) Probable
  Bae 2009 \[[@pone.0126971.ref017]\]                               Korea             1 case (M/76)     Palpable subcutaneous nodule                   Not reported                               BSA                            Bees                                               Not reported            Not reported                                          Not reported                                                           Two erythematous plaques, skin ulcerations, and necrosis                                                                                                                                         Moderate                                            SP                                              \-                                                             Foreign bodygranuloma                                          Probable
  Cheng 2004 \[[@pone.0126971.ref018]\]                             China             2 cases a) M/2    a\) Repeated respiratory infections            a\) MD                                     a\) BSA                        Bees                                               a\) Not reported        a\) 1 bee sting                                       a\) Not reported                                                       a\) Arrhythmia,pallor face, nausea, vomiting, and cold sweats                                                                                                                                    a\) Moderate                                        a\) SR                                          a\) Grade II                                                   a\) Anaphylaxis                                                a\) Probable
                                                                                      b\) M/3           b\) Repeated respiratory infections            b\) MD                                     b\) BSA                        Bees                                               b\) Not reported        b\) 1 bee sting                                       b\) Not reported                                                       b\) Arrhythmia,pallor face, nausea, vomiting, and cold sweats                                                                                                                                    b\) Moderate                                        b\) SR                                          b\) Grade II                                                   b\) Anaphylaxis                                                b\) Probable
  Cho 2010 \[[@pone.0126971.ref019]\]                               Korea             1 case (F/37)     Lower back pain                                KMD                                        BVA                            Bees                                               Not reported            Not reported                                          Not reported                                                           Skin rash, pruritus, arthralgia,fever, and myalgia                                                                                                                                               Moderate                                            SR                                              Grade I                                                        Serum sickness reaction                                        Probable
  Herr 1999 \[[@pone.0126971.ref020]\]                              Korea             1 case (M/64)     Knee arthralgia                                Unqualified person                         BSA                            Bees                                               Not reported            Not reported                                          Not reported                                                           Localized edema and pruritus; skin nodules                                                                                                                                                       Moderate                                            SP                                              \-                                                             Eosinophilic granuloma                                         Probable
  Huh 2008 \[[@pone.0126971.ref021]\]                               Korea             1 case (M/71)     Knee pain                                      Not reported                               BSA                            Bees                                               Not reported            Not reported                                          Not reported                                                           Dysarthria, dizziness, and left hemiparesis                                                                                                                                                      Severe                                              SR                                              Grade III                                                      Pontine and thalamic infarction                                Possible
  Jung 2012 \[[@pone.0126971.ref022]\]                              Korea             1 case (F/65)     Knee pain                                      Unqualified person (apitherapist)          BSA                            Bees                                               Not reported            Not reported                                          Not reported                                                           Nausea, dizziness, weakness, generalized paresthesia, whole-body wheal, diffuse edema, unconsciousness, and death                                                                                Severe                                              SR                                              Grade IV                                                       Anaphylaxis, disseminated intravascular coagulation (DIC)      Probable
  Karapata 1961 \[[@pone.0126971.ref023]\]                          Russia            1 case (M/51)     Hypertensive disorders                         Not reported                               BVA                            Bees                                               Not reported            Not reported                                          Not reported                                                           Vomiting, headache, and uremia                                                                                                                                                                   Severe                                              Others                                          \-                                                             Toxic pulmonary edema                                          Possible
  Kim 2005 \[[@pone.0126971.ref024]\]                               Korea             1 case (F/53)     Pain in the scapular region                    KMD                                        BVA                            Bees                                               Not reported            Not reported                                          Not reported                                                           Localized pruritus and multiple erythematous papules                                                                                                                                             Moderate                                            SP                                              \-                                                             Hypersensitivity                                               Probable
  Kim 2007 \[[@pone.0126971.ref025]\]                               Korea             1 case (F/28)     Not reported                                   Not reported                               BVA                            Bees                                               Not reported            Not reported                                          Not reported                                                           Facial and generalize edema, backache, and abdominal distension                                                                                                                                  Moderate                                            SR                                              Grade II                                                       Minimal change, nephrotic syndrome                             Probable
  Kim 2010 \[[@pone.0126971.ref026]\]                               Korea             1 case (F/36)     Knee osteoarthritis                            KMD                                        BSA                            Bees                                               Not reported            Not reported                                          Not reported                                                           Two erythematous plaques and nodules; skin ulcerations                                                                                                                                           Moderate                                            SP                                              \-                                                             Foreign body granuloma                                         Probable
  Kim 2011 \[[@pone.0126971.ref027]\]                               Korea             1 case (F/75)     Knee and lower back pain                       KMD                                        SBV and BVA                    Bees                                               Not reported            SBV injection 2.4 mL, BV injection 4,000:1, 1.0 mL    Pharmacopuncture                                                       Facial erythema localized erythema generalized pruritus chest discomfort mild dyspnea                                                                                                            Moderate                                            SR                                              Grade II                                                       Anaphylaxis                                                    Probable
  Kwon 2009 \[[@pone.0126971.ref028]\]                              Korea             2 cases a) M/76   a\) Lower back pain, knee osteoarthritis       a\) KMD                                    a\) SBV                        Bees                                               a\) Not reported        a\) Not reported                                      a\) Not reported                                                       a\) Tongue edema, dysarthria, mild dyspnea, localized erythema, and swelling                                                                                                                     a\) Severe                                          a\) SR                                          a\) Grade III b) Grade I                                       a\) Anaphylaxis                                                a\) Probable
                                                                                      b\) F/50          b\) Pain in hand and shoulder joints           b\) KMD                                    b\) SBV                        Bees                                               b\) Not reported        b\) SBV injection 2.2 mL                              b\) Pharmacopuncture                                                   b\) Generalized pruritus and fever                                                                                                                                                               b\) Moderate                                        b\) SR                                          b\) Grade I                                                    b\) Anaphylaxis                                                b\) Probable
  Lee 1996 \[[@pone.0126971.ref029]\]                               Korea             1 case (F/43)     Chronic eczema-like dermatosis                 Not reported                               BSA                            Bees                                               Not reported            Not reported                                          Not reported                                                           Multiple erythematous plaques and nodules                                                                                                                                                        Moderate                                            SP                                                                                                             Foreign body granuloma                                         Probable
  Lee 1996 \[[@pone.0126971.ref030]\]                               Korea             1 case (F/42)     Polyarthralgia                                 Not reported                               BSA                            Bees                                               Not reported            Not reported                                          Not reported                                                           Localized edema and redness; subcutaneous nodules                                                                                                                                                Moderate                                            SP                                                                                                             Foreign body granuloma                                         Probable
  Lee 2000 \[[@pone.0126971.ref031]\]                               Korea             1 case (M/28)     Ankle sprain                                   KMD                                        BVA                            Bees                                               Not reported            Not reported                                          Not reported                                                           Neck stiffness, chest pressure sensation, stridor, and dyspnea                                                                                                                                   Severe                                              SR                                              Grade III                                                      Anaphylaxis                                                    Probable
  Lee 2010 \[[@pone.0126971.ref032]\]                               Korea             1 case (M/59)     Lipoma                                         Not reported                               BSA                            Bees                                               Not reported            Not reported                                          Not reported                                                           Single erythematous plaques                                                                                                                                                                      Moderate                                            SP                                              \-                                                             Foreign body granuloma                                         Probable
  Lee 2011 \[[@pone.0126971.ref033]\]                               Korea             2 cases a) F/53   a\) Knee and lower back pain                   a\) MD                                     a\) BVA (apitoxin injection)   Bees                                               a\) Not tested          a\) Not reported                                      a\) Not reported                                                       a\) Multiple erythematous plaques and nodules, skin ulcerations, and tenderness                                                                                                                  a\) Moderate                                        a\) SP                                          a\) -                                                          a\) Foreign body granuloma                                     a\) Probable
                                                                                      b\) M/59          b\) Foot pain                                  b\) MD                                     b\) BVA (apitoxin injection)   Bees                                               b\) Not tested          b\) Not reported                                      b\) Not reported                                                       b\) Multiple erythematous plaques and nodules, skin ulcerations, and tenderness                                                                                                                  b\) Moderate                                        b\) SP                                          b\) -                                                          b\) Foreign body granuloma                                     b\) Probable
  Lee 2013 \[[@pone.0126971.ref034]\]                               Korea             1 case (M/50)     Back pain                                      KMD                                        BSA                            Bees                                               Not reported            Not reported                                          Not reported                                                           Multiple erythematous plaques and nodules                                                                                                                                                        Moderate                                            SP                                              \-                                                             Chronic folliculitis and granuloma                             Probable
  Li 2002 \[[@pone.0126971.ref035]\]                                China             1 case (F/63)     Limb joint pain                                MD                                         BSA                            Bees                                               Not reported            More than 20 bees stings                              Not reported                                                           Pallor face, chest discomfort, dyspnea, dysarthria                                                                                                                                               Severe                                              SR                                              Grade III                                                      Anaphylaxis                                                    Probable
  Li 2005 \[[@pone.0126971.ref036]\]                                China             4 cases a) F/67   a\) Rheumatoid arthritis                       a\) Not reported                           a\) BSA                        Bees                                               a\) Not reported        a\) 3 bee stings                                      a\) Not reported                                                       a\) Generalized pruritus, large amounts of sweat, pallor lip, decreased consciousness, hot feeling of the extremities, chest discomfort, and nausea                                              a\) Severe                                          a\) SR                                          a\) Grade III                                                  a\) Anaphylaxis                                                a\) Probable
                                                                                      b\) F/63          b\) Rheumatoid arthritis                       b\) Not reported                           b\) BSA                        Bees                                               b\) Not reported        b\) Not reported                                      b\) Not reported                                                       b\) Pallor pace (blue violet), tachypnea, dysarthria, and dizziness                                                                                                                              b\) Severe                                          b\) SR                                          b\) Grade III                                                  b\) Anaphylaxis                                                b\) Probable
                                                                                      c\) F/59          c\) Rheumatoid arthritis                       c\) Not reported                           c\) BSA                        Bees                                               c\) Not reported        c\) 2 bee stings                                      c\) Not reported                                                       c\) Localized edema and redness, and generalized urticaria                                                                                                                                       c\) Moderate                                        c\) SR                                          c\) Grade I                                                    c\) Anaphylaxis                                                c\) Probable
                                                                                      d\) F/36          d\) Rheumatoid arthritis                       d\) Not reported                           d\) BSA                        Bees                                               d\) Not reported        d\) 2 bee stings                                      d\) Not reported                                                       d\) Systemic papules, generalized pruritus, localized edema, and redness                                                                                                                         d\) Moderate                                        d\) SR                                          d\) Grade I                                                    d\) Anaphylaxis                                                d\) Probable
  Park 1998 \[[@pone.0126971.ref037]\]                              Korea             1 case (F/52)     Facial papule                                  Self                                       BSA                            Bees                                               Not reported            Not reported                                          Not reported                                                           Ulcerative tumor                                                                                                                                                                                 Moderate                                            SP                                              \-                                                             Eosinophilic foreign body granuloma                            Probable
  Park 2000 \[[@pone.0126971.ref038]\]                              Korea             1 case (M/50)     Not reported                                   Not reported                               BVA                            Bees                                               Not reported            Not reported                                          Not reported                                                           Severe diaphoresis, dizziness, palpitation, dysarthria, and left hemiparesis                                                                                                                     Severe                                              SR                                              Grade III                                                      Ischemic stroke                                                Probable
  Park 2013 \[[@pone.0126971.ref007]\]                              Korea             2 cases a) F/44   a\) Arthralgia pain                            a\) Not reported                           a\) BSA                        Bees                                               a\) Not reported        a\) Not reported                                      a\) Not reported                                                       a\) Ulcerative tumor                                                                                                                                                                             a\) Moderate                                        a\) SP                                          a\) -                                                          a\) Live bee acupuncture dermatitis                            a\) Probable
                                                                                      b\) M/10          b\) Eczema                                     b\) Not reported                           b\) BSA                        Bees                                               b\) Not reported        b\) Not reported                                      b\) Not reported                                                       b\) Whitish plaques with erythematous papules                                                                                                                                                    b\) Moderate                                        b\) SP                                          b\) -                                                          b\) Live bee acupuncture dermatitis                            b\) Probable
  Rhee 2009 \[[@pone.0126971.ref039]\]                              Korea             1 case (M/49)     A small nodule                                 Not reported                               BVA                            Bees                                               Not reported            Not reported                                          Not reported                                                           Erythematous tumor                                                                                                                                                                               Moderate                                            SP                                              \-                                                             Giant dermatofibroma                                           Probable
  Rho 2009 \[[@pone.0126971.ref040]\]                               Korea             1 case (F/49)     Knee arthritis                                 Not reported                               BVA                            Bees                                               Not reported            Not reported                                          Not reported                                                           Fever, dysuria, face edema, and generalized erythematous; popular rash                                                                                                                           Moderate                                            SR                                              Grade I                                                        Systemic lupus erythematosus                                   Possible
  Shim 2011 \[[@pone.0126971.ref041]\]                              Korea             1 case (M/52)     Paralysis                                      KMD                                        BVA                            Bees                                               Not reported            Not reported                                          Not reported                                                           Multiple erythematous plaques and nodules, skin ulcerations, and tenderness                                                                                                                      Severe                                              SP                                              \-                                                             *Mycobacterium chelonae* infection                             Probable
  Song 2002 \[[@pone.0126971.ref042]\]                              Korea             2 cases a) F/42   a\) Pain in the scapular region                a\) Unqualified person                     a\) BSA                        Bees                                               a\) Not reported        a\) Not reported                                      a\) Not reported                                                       a\) Generalized urticaria, facial edema, dyspnea, and chest pain                                                                                                                                 a\) Severe                                          a\) SR                                          a\) Grade II                                                   a\) Anaphylaxis                                                a\) Probable
                                                                                      b\) F/39          b\) Lower back pain                            b\) Unqualified person                     b\) BSA                        Bees                                               b\) Not reported        b\) Not reported                                      b\) Not reported                                                       b\) Facial edema, generalized urticaria, pruritus, lower abdomen pain, and dyspnea                                                                                                               b\) Severe                                          b\) SR                                          b\) Grade II                                                   b\) Anaphylaxis                                                b\) Probable
  Veraldi 1995 \[[@pone.0126971.ref043]\]                           Italy             1 case (M/65)     Spinal column arthrosis                        Not reported                               BSA                            Bees                                               Not reported            Not reported                                          Not reported                                                           Swelling, edema, and numerous inflammatory nodules                                                                                                                                               Severe                                              SP                                              \-                                                             Long-lasting subacute inflammatory reaction                    Probable
  Yoo 1994 \[[@pone.0126971.ref044]\]                               Korea             1 case (M/45)     Lower back pain                                Not reported                               BSA                            Bees                                               Not reported            Not reported                                          Not reported                                                           Generalized erythematous plaques                                                                                                                                                                 Moderate                                            SP                                              \-                                                             Contact urticaria                                              Probable
  Yoon 2012 \[[@pone.0126971.ref045]\]                              Korea             2 cases a) M/33   a\) Lower back pain                            a\) KMD                                    a\) BVA                        Bees                                               a\) Tested (negative)   a\) BV injection 2,000:1, 0.4 mL                      a\) Not reported                                                       a\) Facial edema, generalized pruritus, erythema, respiratory depression, and fever                                                                                                              a\) Severe                                          a\) SR                                          a\) Grade II                                                   a\) Hypersensitivity                                           a\) Probable
                                                                                      b\) F/75          b\) Facial palsy                               b\) KMD                                    b\) BVA                        Bees                                               b\) Tested (negative)   b\) BV injection 2,000:1, 0.4 mL                      b\) Acupuncture, pharmacopuncture, herbal medicine, physical therapy   b\) Localized edema                                                                                                                                                                              b\) Moderate                                        b\) SP                                          b\) -                                                          b\) Hypersensitivity                                           b\) Probable
  Youn 2005 \[[@pone.0126971.ref046]\]                              Korea             2 cases a) F/66   a\) Knee pain                                  a\) KMD                                    a\) BVA                        Bees                                               a\) Not reported        a\) BV injection 2,000:1, 0.2 mL                      a\) Acupuncture, pharmacopuncture                                      a\) Chest discomfort, nausea, dizziness, drowsiness, and chills                                                                                                                                  a\) Moderate                                        a\) SR                                          a\) Grade II                                                   a\) Anaphylaxis                                                a\) Probable
                                                                                      b\) M/39          b\) Posterior neck and shoulder pain           b\) KMD                                    b\) BVA                        Bees                                               b\) Not reported        b\) BV injection 2,000:1, 0.3 mL                      b\) Acupuncture, cupping                                               b\) Chest discomfort, generalized erythema, pruritus, dyspnea, and nausea                                                                                                                        b\) Moderate                                        b\) SR                                          b\) Grade II                                                   b\) Anaphylaxis                                                b\) Probable
  Yu 1998 \[[@pone.0126971.ref047]\]                                Korea             2 cases a) F/43   a\) Pruritic skin eruption                     a\) Not reported                           a\) BSA                        Bees                                               a\) Not reported        a\) Not reported                                      a\) Not reported                                                       a\) Multiple erythematous plaques and nodules, tenderness                                                                                                                                        a\) Moderate                                        a\) SP                                          a\) -                                                          a\) Foreign body granulomas                                    a\) Possible
                                                                                      b\) M/50          b\) Subcutaneous nodule                        b\) Not reported                           b\) BSA                        Bees                                               b\) Not reported        b\) Not reported                                      b\) Not reported                                                       b\) Ill-defined subcutaneous nodules                                                                                                                                                             b\) Moderate                                        b\) SP                                          b\) -                                                          b\) Foreign body granulomas                                    b\) Possible
  Zhang 1994 \[[@pone.0126971.ref048]\]                             China             2 cases a) M/50   a\) Knee joint soft tissue damage              a\) Not reported                           a\) BSA                        Bees                                               a\) Not tested          a\) Not reported                                      a\) Not reported                                                       a\) Localized edema; two ecphymas                                                                                                                                                                a\) Moderate                                        a\) SP                                          a\) -                                                          a\) Live bee acupuncture dermatitis                            a\) Probable
                                                                                      b\) M/29          b\) Lumbodorsal fibromyalgia                   b\) Not reported                           b\) BSA                        Bees                                               b\) Not tested          b\) Not reported                                      b\) Not reported                                                       b\) Generalized pruritus limb paralysis, dyspnea, nausea, vomiting, systemic papules, large amounts of sweat, paralysis, and tremors                                                             b\) Severe                                          b\) SR                                          b\) Grade III                                                  b\) Anaphylaxis                                                b\) Probable
  Zhong 2005 \[[@pone.0126971.ref049]\]                             China             1 case (F/51)     Osteoarthritis pain                            MD                                         BSA                            Bees                                               Not reported            30--40 bee stings                                     Not reported                                                           Anorexia, listlessness, jaundice                                                                                                                                                                 Severe                                              Others                                          \-                                                             Acute icteric hepatitis                                        Possible
  **Venom immunotherapy (VIT)**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
  Anfosso-Capra 1990 \[[@pone.0126971.ref050]\]                     France            1 case (F/49)     Not reported                                   Not reported (performed at the hospital)   Rush VIT                       Wasps                                              Tested (positive)       YJV 60 μg                                             Not reported                                                           Urticaria and cough                                                                                                                                                                              Mild                                                SR                                              Grade I                                                        Hypersensitivity                                               Probable
  Bousquet 1988 \[[@pone.0126971.ref051]\]                          France            4 cases a) M/42   a\) Treatment of systemic allergic reactions   a\) MD                                     a\) VIT                        Bees                                               a\) Tested (positive)   a\) HBV 50 μg                                         a\) Not reported                                                       a\) Angioedema involving the larynx and tracheobronchial tree; hypotension                                                                                                                       a\) Severe                                          a\) SR                                          a\) Grade III                                                  a\) Anaphylaxis                                                a\) Probable
                                                                                      b\) M/16          b\) Treatment of systemic allergic reactions   b\) MD                                     b\) VIT                        Bees                                               b\) Tested (positive)   b\) HBV 100 μg                                        b\) Not reported                                                       b\) Urticaria, tracheobronchial angioedema, and slight hypotension                                                                                                                               b\) Moderate                                        b\) SR                                          b\) Grade II                                                   b\) Anaphylaxis                                                b\) Probable
                                                                                      c\) M/26          c\) Treatment of systemic allergic reactions   c\) MD                                     c\) VIT                        Bees                                               c\) Tested (positive)   c\) HBV 100 μg                                        c\) Not reported                                                       c\) Increased pulse rate and decreased blood pressure                                                                                                                                            c\) Severe                                          c\) SR                                          c\) Grade III                                                  c\) Anaphylaxis                                                c\) Probable
                                                                                      d\) M/19          d\) Treatment of systemic allergic reactions   d\) MD                                     d\) VIT                        Bees                                               d\) Tested (positive)   d\) HBV 100 μg                                        d\) Not reported                                                       d\) Mild hypotension, tachycardia, severe headaches, and erythematous rash                                                                                                                       d\) Severe                                          d\) SR                                          d\) Grade III                                                  d\) Anaphylaxis                                                d\) Probable
  De Bandt 1997 \[[@pone.0126971.ref052]\]                          France            1 case (M/69)     Desensitization of BV                          MD                                         VIT                            Wasps                                              Tested (positive)       Not reported                                          Not reported                                                           Motor loss in the left upper limb, weakness of both lower limbs, high grade fever, generalized rash, an indurated erythematous skin lesion over the left forearm, and arthritis of both wrists   Severe                                              SR                                              Grade III                                                      Serum sickness reaction                                        Probable
  Eming 2004 \[[@pone.0126971.ref053]\]                             Germany           1 case (F/51)     Desensitization of BV                          Not reported                               Rush VIT                       Bees                                               Tested (positive)       Not reported                                          Not reported                                                           Multiple erythematous and subcutaneous nodules                                                                                                                                                   Moderate                                            SP                                              \-                                                             Panniculitis                                                   Possible
  Karakurt 2010 \[[@pone.0126971.ref054]\]                          Turkey            1 case (f/45)     Desensitization of BV                          MD                                         VIT                            Bees                                               Tested (positive)       Not reported                                          Not reported                                                           Painful cyclic uterine contractions                                                                                                                                                              Moderate                                            Others                                          \-                                                             Hypocalcemia or electrolyte imbalance                          Probable
  Lyanga 1982 \[[@pone.0126971.ref055]\]                            Canada            1 case (F/24)     Desensitization of BV                          MD                                         VIT                            Wasps                                              Tested (positive)       Vespid venom 0.433 μg--100 μg                         Not reported                                                           Transient bradycardia                                                                                                                                                                            Moderate                                            Others                                          \-                                                             Idiosyncratic or direct toxic effect                           Probable
  Nemat 2011 \[[@pone.0126971.ref056]\]                             Germany           1 case (F/16)     Desensitization of BV                          MD                                         VIT                            Bees                                               Tested (positive)       Not reported                                          Not reported                                                           Severe pain affecting the left shoulder, chest wall, and left arm; muscular weakness in left the arm and hand; shortness of breath                                                               Severe                                              Others                                          \-                                                             Neuralgic amyotrophy                                           Possible
  Pijak 2011 \[[@pone.0126971.ref057]\]                             Slovak Republic   1 case (M/47)     Because of significant professional risk       Not reported                               VIT                            Wasps                                              Tested (positive)       Not reported                                          Not reported                                                           Elevations of aminotransferases and development of nephrotic syndrome                                                                                                                            Severe                                              Others                                          \-                                                             Hepatitis B reactivation complicated with nephrotic syndrome   Probable
  Reisman 1988 \[[@pone.0126971.ref058]\]                           USA               7 cases a) F/39   a\) Desensitization of BV                      a\) MD                                     a\) VIT                        Mix                                                a\) Tested (positive)   a\) HBV 1.0 μg, YJV 0.1 μg, *Polistes* venom 0.1 μg   a\) Not reported                                                       a\) Nausea, emesis, headache, fever, malaise                                                                                                                                                     a\) Moderate                                        a\) SR                                          a\) Grade II                                                   a\) Late onset reaction                                        a\) Possible
                                                                                      b\) M/40          b\) Desensitization of BV                      b\) MD                                     b\) VIT                        Mix                                                b\) Tested (positive)   b\) HBV 5.0 μg, YJV 2.0 μg                            b\) Not reported                                                       b\) Fatigue, malaise, local swelling                                                                                                                                                             b\) Moderate                                        b\) SR                                          b\) Grade I                                                    b\) Late onset reaction                                        b\) Possible
                                                                                      c\) M/70          c\) Desensitization of BV                      c\) MD                                     c\) VIT                        Mix                                                c\) Tested (positive)   c\) HBV 50.0 μg, YJV 5.0 μg                           c\) Not reported                                                       c\) Generalized aches, joint pain                                                                                                                                                                c\) Moderate                                        c\) Others                                      c\) -                                                          c\) Late onset reaction                                        c\) Possible
                                                                                      d\) M/37          d\) Desensitization of BV                      d\) MD                                     d\) VIT                        Mix                                                d\) Tested (positive)   d\) HBV 0.3 μg, YJV 0.3 μg                            d\) Not reported                                                       d\) Muscle aches, joints sore, difficulty in walking                                                                                                                                             d\) Moderate                                        d\) Others                                      d\) -                                                          d\) Late onset reaction                                        d\) Possible
                                                                                      e\) F/41          e\) Desensitization of BV                      e\) MD                                     e\) VIT                        Wasps                                              e\) Not reported        e\) YJV 50.0 μg                                       e\) Not reported                                                       e\) Chills, fever, aches                                                                                                                                                                         e\) Moderate                                        e\) SR                                          e\) Grade I                                                    e\) Late onset reaction                                        e\) Possible
                                                                                      f\) M/50          f\) Desensitization of BV                      f\) MD                                     f\) VIT                        Wasps                                              f\) Tested (positive)   f\) YJV 50.0 μg                                       f\) Not reported                                                       f\) Asthma, chest tightness                                                                                                                                                                      f\) Moderate                                        f\) Others                                      f\) -                                                          f\) Late onset reaction                                        f\) Possible
                                                                                      g\) M/27          g\) Desensitization of BV                      g\) MD                                     g\) VIT                        Mix                                                g\) Tested (positive)   g\) HBV 0.1 μg, YJV 0.1 μg                            g\) Not reported                                                       g\) Generalized ache, fatigue                                                                                                                                                                    g\) Moderate                                        g\) SR                                          g\) Grade I                                                    g\) Late onset reaction                                        g\) Possible
  Yalcin 2012 \[[@pone.0126971.ref059] ^\]^                         Turkey            1 case (M/61)     Desensitization of BV                          MD                                         VIT                            Bees                                               Tested (positive)       Not reported                                          Not reported                                                           Severe itching, erythematous papules, and plaques                                                                                                                                                Moderate                                            SP                                              \-                                                             Jessner lymphocytic infiltrate                                 Possible

AE: adverse event; BVT: bee venom therapy; BSA: bee sting acupuncture; BVA: bee venom acupuncture; SBV: sweet bee venom; HBV: honeybee venom; KMD: Korean medical doctor; MD: Medical doctor; VIT: venom immunotherapy; YJV: yellow jacket venom.

^a^ Venom type: bees (family Apidae); wasps (family Vespidae); mix (bees and wasps).

^b^ AE severity was assessed using Spilker's criteria: mild, moderate, and severe.

^c^ AE type was classified into 1 of 3 categories: systemic reaction (SR), skin problem (SP), and other.

^d^ Mueller classification: if a systemic reaction occurred as an AE, it was classified into 1 of 5 categories: large local reaction, grade I, grade II, grade III, and grade IV.

^e^ Causality was determined through the WHO-UMC causality scale: certain, probable, possible, unlikely, conditional, and inaccessible.

Audits and cohort studies {#sec020}
-------------------------

AEs were also reported in 79 mainly retrospective audit studies that aimed to assess the safety of BVT ([Table 2](#pone.0126971.t002){ref-type="table"}) \[[@pone.0126971.ref060]--[@pone.0126971.ref138]\]. These studies were chiefly observational and included case-controlled and cohort studies. VIT (63 studies) was the most commonly used BVT method, followed by BSA (9 studies) and BVA (7 studies). The treatment protocol for VITs included conventional VIT, cluster VIT, rush VIT, ultra-rush VIT, specific immunotherapy, and rush-specific immunotherapy. Eleven studies were conducted in Spain, 10 studies were conducted in China, 8 studies were conducted in Italy and the United States, 6 studies were conducted in Germany, 5 studies were conducted in France, Korea, and Switzerland, and 21 studies were conducted in 18 other countries. The prevalence of AEs ranged from 0.00% \[[@pone.0126971.ref060]\] \[[@pone.0126971.ref117]\] \[[@pone.0126971.ref118]\] \[[@pone.0126971.ref134]\] up to 90.63% \[[@pone.0126971.ref109]\]. In the 46 VIT studies, the median incidence (number of patients with AEs/number of patients in all cases, %) of AEs was 28.87% (interquartile range \[IQR\], 14.57--39.74%), and the AE types included SR (50.37%), LR (35.80%), LLR (9.99%), and other (3.85%; blood pressure elevation, moderate hypotension, rhinitis, asthenia or headache, visual disorders and vertigo, transient dyspnea, proteinuria with microscopic hematuria, generalized pruritus without skin lesions or other signs, and not reported).

10.1371/journal.pone.0126971.t002

###### Audits and cohort studies on the adverse events of bee venom therapy

.

![](pone.0126971.t002){#pone.0126971.t002g}

  Study (first author, year)                                        Country                 Prospective or retrospective study[^a^](#t002fn002){ref-type="table-fn"}   Stimulation features of bee venom therapy   Venom type[^b^](#t002fn003){ref-type="table-fn"}   Incidence of AEs[^c^](#t002fn004){ref-type="table-fn"}                                                  Types of AEs (numbers or cases)
  ----------------------------------------------------------------- ----------------------- -------------------------------------------------------------------------- ------------------------------------------- -------------------------------------------------- ------------------------------------------------------------------------------------------------------- ---------------------------------
  **Bee sting acupuncture (BSA) and bee venom acupuncture (BVA)**                                                                                                                                                                                                                                                                                                             
  Castro 2005 \[[@pone.0126971.ref060]\]                            USA                     Prospective study                                                          Bee venom acupuncture                       Bees                                               0/9 (0.00%)                                                                                             LR (minor)
  Choi 2010 \[[@pone.0126971.ref061]\]                              Korea                   Retrospective study                                                        SBV                                         Bees                                               48/374 (12.83%)                                                                                         LR (48)
  Gao 2011 \[[@pone.0126971.ref062]\]                               China                   Retrospective study                                                        Bee sting acupuncture                       Bees                                               395/250[^d^](#t002fn005){ref-type="table-fn"}                                                           \-
  Hwang 2000 \[[@pone.0126971.ref063]\]                             Korea                   Retrospective study                                                        Bee venom acupuncture                       Bees                                               11/32,000 (0.03%)[^g^](#t002fn008){ref-type="table-fn"}                                                 SR (11)
  Jung 2013 \[[@pone.0126971.ref064]\]                              Korea                   Retrospective study                                                        SBV                                         Bees                                               a\) 37/130 (28.46%) b) 41/130 (31.54%)                                                                  a\) LR (37) b) LR (41)
  Kwon 2000 \[[@pone.0126971.ref065]\]                              Korea                   Retrospective study                                                        Bee venom acupuncture                       Bees                                               361/2765 (13.00%)[^e^](#t002fn006){ref-type="table-fn"}                                                 SR (361)
  Li 1995 \[[@pone.0126971.ref066]\]                                China                   Retrospective study                                                        Bee sting acupuncture                       Bees                                               186/160[^d^](#t002fn005){ref-type="table-fn"}                                                           \-
  Liu 1993 \[[@pone.0126971.ref067]\]                               China                   Retrospective study                                                        Bee sting acupuncture                       Bees                                               96/32[^d^](#t002fn005){ref-type="table-fn"}                                                             \-
  Ma 2008 \[[@pone.0126971.ref068]\]                                China                   Retrospective study                                                        Bee venom acupuncture                       Bees                                               7/40[^d^](#t002fn005){ref-type="table-fn"}                                                              \-
  Tang 2003 \[[@pone.0126971.ref069]\]                              China                   Retrospective study                                                        Bee sting acupuncture                       Bees                                               20/468 (4.27%)                                                                                          SR (20)
  Wen 2003 \[[@pone.0126971.ref070]\]                               China                   Retrospective study                                                        Bee sting acupuncture                       Bees                                               12/40[^d^](#t002fn005){ref-type="table-fn"}                                                             \-
  Xiao 2013 \[[@pone.0126971.ref071]\]                              China                   Retrospective study                                                        Bee sting acupuncture                       Bees                                               4902/4960 (98.83%)[^e^](#t002fn006){ref-type="table-fn"}                                                LR (4902)
  Yoon 2012 \[[@pone.0126971.ref072]\]                              Korea                   Prospective study                                                          SBV                                         Bees                                               2/11 (18.18%)                                                                                           LR (2)
  Yu 2006 \[[@pone.0126971.ref073]\]                                China                   Retrospective study                                                        Bee sting acupuncture                       Bees                                               30/250 (12.00%)                                                                                         SR (30)
  Zhang 2010 \[[@pone.0126971.ref074]\]                             China                   Retrospective study                                                        Bee sting acupuncture                       Bees                                               141/120[^d^](#t002fn005){ref-type="table-fn"}                                                           \-
  Zhou 2009 \[[@pone.0126971.ref075]\]                              China                   Retrospective study                                                        Bee sting acupuncture                       Bees                                               3/40 (7.50%)                                                                                            SR (3)
  Venom immunotherapy (VIT)                                                                                                                                                                                                                                                                                                                                                   
  Aguilar 1999 \[[@pone.0126971.ref076]\]                           Spain                   Retrospective study                                                        CVIT                                        Mix                                                12/70 (17.14%)                                                                                          SR (4), LR (5), Others (3)
  Alessandrini 2006 \[[@pone.0126971.ref077]\]                      Italy                   Prospective study                                                          VIT                                         Wasps                                              40/107 (37.38%)                                                                                         SR (7), LR (33)
  Anguita Carazo 2011 \[[@pone.0126971.ref078]\]                    Spain                   Retrospective study                                                        VIT                                         Hymenoptera                                        35/2,935 (1.19%)[^e^](#t002fn006){ref-type="table-fn"}                                                  SR (9), LR (26)
                                                                                                                                                                                                                   Bees                                               12/1291 (0.93%)                                                                                         SR (9), LR (3)
                                                                                                                                                                                                                   Wasps                                              23/1644 (1.40%)                                                                                         SR (0), LR (23)
  Bemanian 2007 \[[@pone.0126971.ref079]\]                          Iran                    Prospective study                                                          CVIT                                        Mix                                                8/120 (6.66%)[^e^](#t002fn006){ref-type="table-fn"}                                                     SR (8)
  Bernstein 1989 \[[@pone.0126971.ref080]\]                         USA                     Retrospective study                                                        Rapid VIT                                   Single or mix                                      19/33 (57.58%)                                                                                          SR (4), LR (18)
  Bernstein 1994 \[[@pone.0126971.ref081]\]                         USA                     Retrospective study                                                        VIT                                         Single or mix                                      4/77 (5.19%)                                                                                            SR (4)
  Birnbaum 1993 \[[@pone.0126971.ref082]\]                          France                  Retrospective study                                                        RVIT                                        Hymenoptera                                        34/284 (11.97%)                                                                                         SR (34)
                                                                                                                                                                                                                   Bees                                               24/91 (26.37%)                                                                                          SR (24)
                                                                                                                                                                                                                   Wasps                                              10/193 (5.18%)                                                                                          SR (10)
  Birnbaum 2003 \[[@pone.0126971.ref083]\]                          France                  Retrospective study                                                        Ultra-RVIT                                  Single or mix                                      36/325 (11.08%)                                                                                         SR (36)
  Bonadonna 2008 \[[@pone.0126971.ref084]\]                         Italy                   Retrospective study                                                        SIT                                         Single                                             2/16 (12.50%)                                                                                           SR (1), Others (1)
  Bonadonna 2013 \[[@pone.0126971.ref085]\]                         Italy and Spain         Prospective study                                                          VIT                                         Single or mix                                      10/84 (11.90%)                                                                                          SR (4), LLR (6)
  Brehler 2000 \[[@pone.0126971.ref086]\]                           Germany                 Retrospective study                                                        VIT                                         Single                                             224/1,055 (21.23%)[^e^](#t002fn006){ref-type="table-fn"}                                                SR (160), LR (124)
  Bucher 2003 \[[@pone.0126971.ref087]\]                            Switzerland             Retrospective study                                                        Ultra-RVIT                                  Hymenoptera                                        127/179 (70.95%)                                                                                        SR (24), LR (103)
                                                                                                                                                                                                                   Bees                                               63/85 (74.12%)                                                                                          SR (18), LR (45)
                                                                                                                                                                                                                   Wasps                                              64/94 (68.09%)                                                                                          SR (6), LR (58)
  Cadario 2004 \[[@pone.0126971.ref088]\]                           Italy                   Prospective study                                                          VIT                                         Single                                             15/45 (33.33%)                                                                                          SR (4), LR (11)
  Calaforra 2009 \[[@pone.0126971.ref089]\]                         Spain                   Retrospective study                                                        CVIT                                        Single                                             22/863 (2.55%)[^e^](#t002fn006){ref-type="table-fn"}                                                    SR (15), LR (7)
  Carballada 2003 \[[@pone.0126971.ref090]\]                        Spain                   Retrospective study                                                        VIT                                         Single                                             52/241 (21.58%)                                                                                         SR (22), LR (31)
  Carballada Gonzalez 2009 \[[@pone.0126971.ref091]\]               Spain                   Retrospective study                                                        VIT                                         Hymenoptera                                        5/21 (23.81%)                                                                                           SR (2), LR (3)
                                                                                                                                                                                                                   Bees                                               5/17 (29.41%)                                                                                           SR (2), LR (3)
                                                                                                                                                                                                                   Wasps                                              -0/4 (0.00%)                                                                                            
  Catalá 2009 \[[@pone.0126971.ref092]\]                            Spain                   Retrospective study                                                        CVIT                                        Single                                             7/180 (3.89%)[^e^](#t002fn006){ref-type="table-fn"}                                                     SR (2), LLR (3), Others (2)
  Caubet 2008 \[[@pone.0126971.ref093]\]                            Switzerland             Retrospective study                                                        Subcutaneous IT                             Hymenoptera                                        173/1,278 (13.54%)[^e^](#t002fn006){ref-type="table-fn"}                                                SR (53), LLR (120)
  Cavallucci 2010 \[[@pone.0126971.ref094]\]                        Italy                   Retrospective study                                                        VIT                                         Single                                             a\) IP 32/72 (44.44%)                                                                                   a\) SR (9), LR (23)
                                                                                                                                                                                                                                                                      b\) EP 22/72 (30.56%)                                                                                   b\) SR (4), LR (18)
                                                                                                                                                                                                                                                                      c\) MP 17/72 (23.61%)                                                                                   c\) SR (0), LR (17)
  De Jong 1999 \[[@pone.0126971.ref095]\]                           Netherlands             Retrospective study                                                        VIT                                         Bees                                               14/194 (7.22%)[^e^](#t002fn006){ref-type="table-fn"}                                                    SR (2), LR (12)
  Dursun 2006 \[[@pone.0126971.ref096]\]                            Turkey                  Retrospective study                                                        VIT                                         Mix                                                2/20 (10.00%)                                                                                           SR (2)
  Eben 2010 \[[@pone.0126971.ref097]\]                              Germany                 Retrospective study                                                        VIT                                         Single                                             54/159 (33.96%)                                                                                         SR (36), Others (18)
  Gastaminza 2003 \[[@pone.0126971.ref098]\]                        Spain                   Retrospective study                                                        VIT                                         Mix                                                \<250/4973 (\<5.03%)[^e^](#t002fn006){ref-type="table-fn"} ^,^ [^f^](#t002fn007){ref-type="table-fn"}   SR (\<79)
  Goldberg 2011 \[[@pone.0126971.ref099]\]                          Israel                  Retrospective study                                                        RVIT                                        Single or mix                                      53/179 (29.61%)                                                                                         SR (53)
  Golden 1980 \[[@pone.0126971.ref100]\]                            USA                     Retrospective study                                                        Slow VIT, RVIT, or Step VIT                 Single or mix                                      42/64 (65.63%)                                                                                          SR (10), LLR (32)
  Golub 1984 \[[@pone.0126971.ref101]\]                             USA                     Retrospective study                                                        VIT                                         Single or mix                                      10/41 (24.39%)                                                                                          SR (1), LR (9)
  Gonzalez de Olando 2008 \[[@pone.0126971.ref102]\]                Spain                   Retrospective study                                                        VIT                                         Single or mix                                      6/21 (28.57%)                                                                                           SR (6)
  Gorska 2008 \[[@pone.0126971.ref103]\]                            Poland                  Retrospective study                                                        RVIT                                        Hymenoptera                                        18/118 (15.25%)                                                                                         SR (18)
                                                                                                                                                                                                                   Bees                                               8/28 (28.57%)                                                                                           SR(8)
                                                                                                                                                                                                                   Wasps                                              10/90 (11.11%)                                                                                          SR(10)
  Hirata 2003 \[[@pone.0126971.ref104]\]                            Japan                   Retrospective study                                                        RVIT                                        Single or mix                                      3/95 (3.16%)                                                                                            SR (3)
  Kerddonfak 2009 \[[@pone.0126971.ref105]\]                        Thailand                Retrospective study                                                        RVIT                                        Single or mix                                      \<4/6 (\<66.67%)[^f^](#t002fn007){ref-type="table-fn"}                                                  SR (\<3), LLR (\<1)
  Kalogeromitros 2009 \[[@pone.0126971.ref106]\]                    USA                     Prospective study                                                          RVIT                                        Single or mix                                      9/49 (18.37%)                                                                                           SR (9)
  Köhli-Wiesner 2012 \[[@pone.0126971.ref107]\]                     Switzerland             Retrospective study                                                        Ultra-RVIT                                  Single or mix                                      16/94 (17.02%)[^e^](#t002fn006){ref-type="table-fn"}                                                    SR (13), Others (3)
  Kopaè 2009 \[[@pone.0126971.ref108]\]                             Slovenia                Retrospective study                                                        Ultra-RVIT                                  Single                                             14/77 (18.18%)                                                                                          SR (10), LLR (4)
  Lata 2005 \[[@pone.0126971.ref109]\]                              Poland                  Retrospective study                                                        SIT                                         Mix                                                29/32 (90.63%)                                                                                          SR (6), LR(23)
  Laurent 1997 \[[@pone.0126971.ref110]\]                           France                  Retrospective study                                                        RVIT                                        Single or mix                                      39/97 (40.21%)                                                                                          LLR (9), Others (30)
  Lee 2006 \[[@pone.0126971.ref111]\]                               Germany                 Prospective study                                                          Ultra-RVIT                                  Wasps                                              28/110 (25.45%)                                                                                         SR (5), LLR (23)
  Marquès 2010 \[[@pone.0126971.ref112]\]                           Spain                   Retrospective study                                                        VIT                                         Single or mix                                      184/536 (34.33%)                                                                                        SR (35), LR (149)
  Mellerup 2000 \[[@pone.0126971.ref113]\]                          Denmark                 Retrospective study                                                        VIT                                         Mix                                                14/117 (11.97%)                                                                                         SR (14)
  Mingomataj 2002 \[[@pone.0126971.ref114]\]                        Albania                 Retrospective study                                                        RSIT                                        Single                                             16/37 (43.24%)                                                                                          SR (16)
  Mosbech 2000 \[[@pone.0126971.ref115]\]                           10 European countries   Prospective study                                                          VIT                                         Single or mix                                      20.00%                                                                                                  \-
  Müller 1992 \[[@pone.0126971.ref116]\]                            Switzerland             Retrospective study                                                        RVIT or VIT                                 Hymenoptera                                        74/205 (36.10%)                                                                                         SR (74)
                                                                                                                                                                                                                   Bees                                               60/148 (40.54%)                                                                                         SR (60)
                                                                                                                                                                                                                   Wasps                                              14/57 (24.56%)                                                                                          -R (14)
  Nagai 2004 \[[@pone.0126971.ref117]\]                             Japan                   Retrospective study                                                        RVIT                                        Mix                                                0/2 (0.00%)                                                                                             \-
  Nataf 1984 \[[@pone.0126971.ref118]\]                             France                  Retrospective study                                                        RVIT                                        Mix                                                0/54 (0.00%)[^g^](#t002fn008){ref-type="table-fn"}                                                      \-
  Pasaoglu 2006 \[[@pone.0126971.ref119]\]                          Turkey                  Retrospective study                                                        RVIT                                        Hymenoptera                                        15/469 (3.20%)[^e^](#t002fn006){ref-type="table-fn"}                                                    SR (4), LR(11)
                                                                                                                                                                                                                   Bees                                               12/240 (5.00%)                                                                                          SR (4), LR(8)
                                                                                                                                                                                                                   Wasps                                              3/229 (1.31%)                                                                                           LR(3)
  Poli 2001 \[[@pone.0126971.ref120]\]                              Italy                   Retrospective study                                                        VIT                                         Wasps                                              2/36 (5.56%)                                                                                            LR (2)
  Quercia 2001 \[[@pone.0126971.ref121]\]                           Italy                   Retrospective study                                                        RVIT or CVIT                                Bees                                               17/55 (30.91%)                                                                                          SR (8) LLR (9)
  Quercia 2006 \[[@pone.0126971.ref122]\]                           Italy                   Prospective study                                                          VIT or CVIT                                 Bees                                               a\) IP 20/68 (29.41%)                                                                                   a\) SR (9) LR (11)
                                                                                                                                                                                                                                                                      b\) MP 5/68 (7.35%)                                                                                     b\) SR (5)
  Ramirez 1981 \[[@pone.0126971.ref123]\]                           USA                     Retrospective study                                                        VIT                                         Hymenoptera                                        36/859 (4.19%)[^e^](#t002fn006){ref-type="table-fn"}                                                    LLR(36)
  Rocklin 1982 \[[@pone.0126971.ref124]\]                           USA                     Retrospective study                                                        VIT                                         Single                                             1/1032 (0.01%)[^e^](#t002fn006){ref-type="table-fn"}                                                    SR(1)
  Roll 2006 \[[@pone.0126971.ref125]\]                              Switzerland             Retrospective study                                                        Ultra-RVIT                                  Single or mix                                      14/80 (17.50%)                                                                                          SR (10), LLR (4)
  Roumana 2009 \[[@pone.0126971.ref126]\]                           Greece                  Retrospective study                                                        RVIT or Ultra-RVIT                          Single or mix                                      219/8,030 (2.73%)[^e^](#t002fn006){ref-type="table-fn"}                                                 SR (219)
  Ruëff 1997 \[[@pone.0126971.ref127]\]                             Germany                 Retrospective study                                                        RVIT                                        Hymenoptera                                        57/144 (39.58%)                                                                                         SR (57)
                                                                                                                                                                                                                   Bees                                               11/28 (39.29%)                                                                                          SR (11)
                                                                                                                                                                                                                   Wasps                                              46/116 (39.66%)                                                                                         SR (46)
  Ruëff 2004 \[[@pone.0126971.ref128]\]                             Germany                 Prospective study                                                          SIT                                         Bees                                               a\) IP 39/65 (60.00%)                                                                                   a\) SR (16), LLR (23)
                                                                                                                                                                                                                                                                      b\) MP33/46 (71.74%)                                                                                    b\) SR (8), LLR (25)
  Sánchez-Machín 2010 \[[@pone.0126971.ref129]\]                    Spain                   Retrospective study                                                        CVIT                                        Bees                                               25/54 (46.30%)                                                                                          SR(2), LR (23)
  Sánchez-Morillas 2005 \[[@pone.0126971.ref130]\]                  Spain                   Retrospective study                                                        RVIT                                        Single or mix                                      14/48 (29.17%)                                                                                          SR (2), LR (12)
  Schiavino 2004 \[[@pone.0126971.ref131]\]                         Italy                   Retrospective study                                                        Ultra-RVIT                                  Hymenoptera                                        20/57 (35.09%)                                                                                          SR (4) LR (16)
                                                                                                                                                                                                                   Bees                                               5/9 (55.56%)                                                                                            SR (1) LR (4)
                                                                                                                                                                                                                   Wasps                                              15/48(31.25%)                                                                                           SR (3) LR (12)
  Sporcic 2009 \[[@pone.0126971.ref132]\]                           Serbia and Montenegro   Retrospective study                                                        VIT                                         Single or mix                                      6/14 (42.86%)                                                                                           SR (2), LR (4)
  Sturm, 2002 \[[@pone.0126971.ref133]\]                            Austria                 Retrospective study                                                        RVIT                                        Single                                             7/101 (6.93%)                                                                                           SR (7)
  Tarhini 1992 \[[@pone.0126971.ref134]\]                           France                  Prospective study                                                          CVIT                                        Single or mix                                      0/100 (0.00%)                                                                                           \-
  Thurnheer 1983 \[[@pone.0126971.ref135]\]                         Sweden                  Retrospective study                                                        RVIT or VIT                                 Single or mix                                      24/42 (57.14%)                                                                                          SR (16) LLR (8)
  Wenzel 2003 \[[@pone.0126971.ref136]\]                            Germany                 Retrospective study                                                        RVIT                                        Single or mix                                      32/178 (17.98%)                                                                                         SR (32)
  Westall 2001 \[[@pone.0126971.ref137]\]                           Australia               Retrospective study                                                        RVIT                                        Hymenoptera                                        26/68 (38.24%)                                                                                          SR (26)
                                                                                                                                                                                                                   Bees                                               25/60 (41.67%)                                                                                          SR (25)
                                                                                                                                                                                                                   Wasps                                              1/8 (12.50%)                                                                                            SR (1)
  Youlten 1995 \[[@pone.0126971.ref138]\]                           UK                      Retrospective study                                                        VIT                                         Hymenoptera                                        24/109 (22.02%)                                                                                         SR (24)
                                                                                                                                                                                                                   Bees                                               12/83 (14.46%)                                                                                          SR (12)
                                                                                                                                                                                                                   Wasps                                              12/26 (46.15%)                                                                                          SR (12)

AE: adverse event; SR: systemic reaction; LR: local reaction; LLR: large local reaction; VIT: venom immunotherapy; RVIT: rush VIT; SIT: specific immunotherapy; RSIT: rush-specific immunotherapy; CVIT; cluster VIT; IP: induction phase; EP: extension phase; MP: maintenance phase.

^a^ If it was not reported in prospective articles, it was considered a retrospective study.

^b^ Venom type: bees (family Apidae); wasps (family Vespidae); single (some bee venom or some wasp venom); mix (bee and wasp venom).

^c^ Incidence: number of patients with AEs/number of patients of total cases, %

^d^ Incidence: number of cases with AEs/number of patients of total cases.

^e^ Incidence: number of injections (dose) that resulted in AEs/total number of injections (dose), % (if the number of patients with AEs was not mentioned or precisely presented).

^f^ Incidence of AEs caused by BVTs combined with the incidence of AEs from other allergens.

^g^ This study was the only report of anaphylaxis related to BVT.

RCTs and randomized crossover trials {#sec021}
------------------------------------

Eighteen RCTs and 2 randomized crossover trials were included in this review ([Table 3](#pone.0126971.t003){ref-type="table"}) \[[@pone.0126971.ref139]--[@pone.0126971.ref158]\]. One-hundred and forty-eight AEs related to BVT were reported in 397 participants. Seventeen patients ended their study participation owing to BVT-related AEs. For the BSA and BVA studies, all of the participants who were negative for skin allergy tests were included in the studies. With regard to the quality of the reporting of AEs, more than half of the items in the CONSORT AE reporting guidelines were not reported (52.14%). Most RCTs did not report the AEs in the title, abstract, or introduction, or report definitions of AEs and mention the methods for analyzing and presenting AEs. In 9 studies, the collecting and monitoring method for AEs involved retrospectively checking with the physician and/or participant, and the monitoring methods of 7 studies were not reported appropriately. Most studies reported the number of patients who stopped participating, as well as the specific denominator for the analysis of BVT-related AEs.

10.1371/journal.pone.0126971.t003

###### Randomized controlled trials and randomized crossover trials reporting adverse events of bee venom therapy.

![](pone.0126971.t003){#pone.0126971.t003g}

  Study (first author, year)                                        Disease type                                                      Intervention            Control                                     Skin test           Incidence and type of AEs[^a^](#t003fn002){ref-type="table-fn"}                                                                                                                                              Quality of AE reporting (CONSORT items for reporting AEs)[^b^](#t003fn003){ref-type="table-fn"}                                                                                                                                                                                                                                                              
  ----------------------------------------------------------------- ----------------------------------------------------------------- ----------------------- ------------------------------------------- ------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------------ -------------- -------------- -------------- ----------------------------------------------------------------------------------- -------------- ----------------------------------------------------------------- --------------
  **Bee sting acupuncture (BSA) and bee venom acupuncture (BVA)**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
  Cho 2012 \[[@pone.0126971.ref139]\]                               Idiopathic Parkinson's disease (RCT)                              BVA                     Acupuncture; no treatment                   Tested (negative)   0/18                                                                                                                                                                                                         0/17; 0/14                                                                                                                                 Not reported   Not reported   Not reported   Moderate (retrospective checking by participant)                                    Not reported   Moderate (1 drop-out because of pruritus)                         Moderate
  Cho 2013 \[[@pone.0126971.ref140]\]                               Central post-stroke pain (RCT)                                    BVA                     Normal saline injection                     Tested (negative)   0/10                                                                                                                                                                                                         0/10                                                                                                                                       Not reported   Not reported   Not reported   Bad                                                                                 Not reported   Moderate (1 drop-out because of pruritus)                         Moderate
  Deng 2011 \[[@pone.0126971.ref141]\]                              Rheumatoid arthritis (RCT)                                        BSA                     Methotrexate; Prednisone and methotrexate   Tested (negative)   5/20 (localized swelling and pruritus, fever (3), nausea (2))                                                                                                                                                4/20 (nausea (3), leukopenia (1)); 9/20 (nausea, flatulence (6), mental excitation, insomnia (3))                                          Moderate       Bad            Not reported   Moderate (retrospective checking by physician)                                      Good           Not reported                                                      Good
  Gwak 2009 \[[@pone.0126971.ref142]\]                              Central post-stroke (RCT)                                         BVA                     Normal saline injection                     Tested (negative)   Not reported                                                                                                                                                                                                 Not reported                                                                                                                               Not reported   Not reported   Not reported   Moderate (retrospective checking by participant)                                    Not reported   Moderate (1 drop-out because of pruritus)                         Not reported
  Kim 2005 \[[@pone.0126971.ref143]\]                               Sprain of C-spine (RCT)                                           BVA and acupuncture     Normal saline injection and acupuncture     Tested (negative)   Not reported                                                                                                                                                                                                 Not reported                                                                                                                               Not reported   Not reported   Bad            Bad                                                                                 Not reported   Moderate (1 drop-out because of hypersensitivity)                 Not reported
  Ko 2007 \[[@pone.0126971.ref144]\]                                Shoulder pain after stroke (RCT)                                  BVA                     Normal saline injection                     Tested (negative)   13/24 (pruritus (8), burning, sensation (3), pain (2))                                                                                                                                                       6/22 (pruritus (2), burning sensation (1), pain (3))                                                                                       Not reported   Not reported   Bad            Moderate (retrospective checking by physician)                                      Not reported   Not reported                                                      Good
  Koh 2013 \[[@pone.0126971.ref145]\]                               Adhesive capsulitis (RCT)                                         BVA and physiotherapy   Normal saline injection and physiotherapy   Tested (negative)   31/45 (slight pruritus, local swelling, and/or redness (30), mild, generalized swelling and aching (1))                                                                                                      3/23 (slight redness and pruritus)                                                                                                         Not reported   Not reported   Bad            Moderate (retrospective checking by physician)                                      Not reported   Moderate (1 drop-out because of allergic response)                Good
  Ku 2010 \[[@pone.0126971.ref146]\]                                Carpal tunnel syndrome (RCT)                                      BVA                     Scolopendrid pharmacopuncture               Tested (negative)   0/11                                                                                                                                                                                                         Not reported                                                                                                                               Moderate       Not reported   Bad            Bad                                                                                 Not reported   Moderate (1 drop-out because of allergic response)                Bad
  Lee 2003 \[[@pone.0126971.ref147]\]                               Rheumatoid arthritis (RCT)                                        BVA                     Normal saline injection                     Tested (negative)   Not reported                                                                                                                                                                                                 Not reported                                                                                                                               Not reported   Not reported   Not reported   Bad                                                                                 Not reported   Moderate (2 drop-out because of pruritus)                         Not reported
  Noh 2010 \[[@pone.0126971.ref148]\]                               Upper limb spasticity after stroke (randomized crossover trial)   BVA                     Normal saline injection                     Tested (negative)   Not reported                                                                                                                                                                                                 Not reported                                                                                                                               Not reported   Not reported   Not reported   Not reported                                                                        Not reported   Moderate (2 drop-out because of pruritus)                         Not reported
  Rong 2002 \[[@pone.0126971.ref149]\]                              Rheumatoid arthritis (RCT)                                        BSA                     Methotrexate, auranofin, and NSAIDs         Tested (negative)   3/20 (fever, localized erythema (3))                                                                                                                                                                         9/20 (stomach discomfort and pain, nausea, loss of appetite, diarrhea, mouth dry, rash (9))                                                Not reported   Bad            Bad            Moderate (retrospective checking by physician)                                      Moderate       Moderate (no drop-out)                                            Good
  Shin 2012 \[[@pone.0126971.ref150]\]                              Chronic low back pain (RCT)                                       BVA                     Normal saline injection                     Tested (negative)   17/30 (pruritus (15), erythema (5), edema (4), skin rash (2))                                                                                                                                                3/30 (skin rash (1), headache (1), hand and foot tingling (1))                                                                             Moderate       Not reported   Good           Good (retrospective checking by physician, research coordinator, and participant)   Good           Moderate (1 drop-out because of pruritus)                         Good
  Song 2005 \[[@pone.0126971.ref151]\]                              Acute ankle sprain (RCT)                                          BVA                     Normal saline injection                     Not reported        Not reported                                                                                                                                                                                                 Not reported                                                                                                                               Not reported   Not reported   Not reported   Bad                                                                                 Not reported   Moderate (1 drop-out because of pruritus)                         Not reported
  Wen 2011 \[[@pone.0126971.ref152]\]                               Ankylosing spondylitis (RCT)                                      BSA                     Sulfasalazine                               Tested (negative)   4/40 (pruritus, skin eruption (3), slight fever (1))                                                                                                                                                         10/40 (epigastric discomfort slight pain, nausea (9), hepatic function abnormal (3), leukopenia (1), drug hypersensitivity syndrome (1))   Good           Bad            Bad            Not reported                                                                        Not reported   Not reported                                                      Good
  Wen 2012 \[[@pone.0126971.ref153]\]                               Ankylosing spondylitis (RCT)                                      BSA                     Sulfasalazine                               Tested (negative)   4/30 (pruritus, skin eruption (3), slight fever (1))                                                                                                                                                         12/30 (epigastric discomfort slight pain, nausea (7), hepatic function abnormal (2), leukopenia (2), drug hypersensitivity syndrome (1))   Good           Not reported   Not reported   Not reported                                                                        Not reported   Not reported                                                      Good
  Wesselius 2005 \[[@pone.0126971.ref154]\]                         Multiple sclerosis (randomized crossover trial)                   BVT                     No treatment                                Tested (negative)   11/26 (extreme localized swelling (2), pruritus (4), flulike symptoms (5), no serious AEs)                                                                                                                   0/26                                                                                                                                       Moderate       Not reported   Not reported   Moderate (retrospective checking by physician and participant)                      Not reported   Not reported                                                      Good
  Won 1999 \[[@pone.0126971.ref155]\]                               Knee or spinal osteoarthritis (RCT)                               BVA                     Nabumetone                                  Tested (negative)   60/76 (pruritus (60), chill and pain (49), local pain (36), edema (25), muscle pain (16), headache (14), fever (13), nausea (4), sweating (3), fatigue (3), vertigo (3), vomiting (1), abdominal pain (1))   Not reported                                                                                                                               Good           Good           Good           Moderate                                                                            Good           Moderate (2 drop-out because of blisters (1) and urticaria (1))   Good
  Yoo 2008 \[[@pone.0126971.ref156]\]                               Cancer-related pain (RCT)                                         SBV                     Normal saline injection                     Tested (negative)   Not reported                                                                                                                                                                                                 Not reported                                                                                                                               Not reported   Not reported   Not reported   Bad                                                                                 Not reported   Moderate (1 drop-out because of pain aggravation)                 Not reported
  Venom immunotherapy (VIT)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
  Oude Elberink 2002 \[[@pone.0126971.ref157]\]                     Desensitization of BV (RCT)                                       VIT (YJV)               EpiPen                                      Tested (positive)   Not reported                                                                                                                                                                                                 Not reported                                                                                                                               Not reported   Not reported   Good           Moderate (retrospective checking by physician)                                      Not reported   Bad (2 drop-out because of AEs)                                   Moderate
  Oude Elberink 2006 \[[@pone.0126971.ref158]\]                     Desensitization of BV (RCT)                                       VIT (YJV)               EpiPen                                      Tested (positive)   0/47 (no systemic AEs reported)                                                                                                                                                                              Not reported                                                                                                                               Not reported   Not reported   Not reported   Bad                                                                                 Not reported   Not reported                                                      Moderate

AE: adverse event; BVT: bee venom therapy; BSA: bee sting acupuncture; BVA: bee venom acupuncture; SBV: sweet bee venom; VIT: venom immunotherapy; YJV: yellow jacket venom. Quality of reporting: good, clear, and well described; moderate, described but not in detail; bad, inappropriately described; not reported, not described at all.

^a^ Incidence: number of patient with AEs/number of patients of total cases, %.

^b^ CONSORT items for reporting AEs: 1, statement of AEs in title or abstract; 2, statement of BVT related AEs in the introduction; 3, predefined definition of AEs related to the BVT; 4, collection or monitoring method for AEs; 5, statement of the method for analyzing and presenting AEs; 6, statement of any patients who dropped out due to AEs; 7, description of the specific denominator for the analysis of AEs.

The meta-analysis of AE occurrence in the 4 RCTs assessing patients experiencing AEs showed that BVA increased the risk of AEs by 261% compared to the risk associated with normal saline control treatment (relative risk, 3.61; 95% CI \[2.10, 6.20\], [Fig 2](#pone.0126971.g002){ref-type="fig"}).

![Relative risk of adverse events in randomized controlled trials with bee venom therapy and saline.](pone.0126971.g002){#pone.0126971.g002}

Discussion {#sec022}
==========

The aim of our systematic review was to summarize the evidence pertaining to BVT-related AEs by analyzing AE types and their prevalence in patients. We reviewed 145 studies, including 20 RCTs and randomized crossover studies, 79 audits and cohort studies, 33 single-case studies, and 13 case series. According to our findings, BVT can lead to AEs such as SRs, LLRs, LRs, SPs, and nonspecific reactions, some of which are serious.

In case studies and case series, we found that SRs comprised 51.72% of the AEs produced by bee venom. Moreover, the identified severe AEs included 14 cases of grade III SR and 1 case of grade IV SR (50.00% of the total SRs). We also found that there have been SAEs associated with BVT that urgently required subcutaneous adrenaline or steroid and oxygen therapy, with death occurring in 1 case \[[@pone.0126971.ref022]\] \[[@pone.0126971.ref051]\] \[[@pone.0126971.ref058]\]. Aside from SRs, AEs associated with BSA and BVA mainly include SPs such as granulomas and plaques, which may be attributable to persistent local inflammation caused by venomic components or from the remaining stinger at the site of cutaneous injection \[[@pone.0126971.ref029]\]. In contrast, SRs resulting from BVT are mainly derived from anaphylaxis, hypersensitivity, and late-onset reactions \[[@pone.0126971.ref003]\] \[[@pone.0126971.ref058]\].

In 46 audits and cohort studies of VIT, the median incidence of AEs was 28.87%, and SRs occurred in 681/4844 (14.06%) participants. These results suggest a more frequent AE incidence in comparison with that in previous systematic reviews of VIT, which reported SR incidences of 11.5 to 11.8% \[[@pone.0126971.ref159]\] \[[@pone.0126971.ref160]\]. Interestingly, some studies found a complete lack of AEs related to BVT and a corresponding lack of SRs, and some studies have shown minor AEs, but no serious SRs \[[@pone.0126971.ref060]\] \[[@pone.0126971.ref117],[@pone.0126971.ref118]\] \[[@pone.0126971.ref134]\].

Skin tests allow practitioners to distinguish whether BVT is an appropriate intervention for particular patients. In most RCTs and randomized crossover trials with BSA and BVA, participants were included if they showed negative responses in skin tests, whereas participants were included in VIT case studies and case series if they showed positive responses in skin tests. This difference in the participants included in each type of study does not seem to be directly related to the AEs associated with BVT; negative venom skin test results are not always a guarantee of VIT safety \[[@pone.0126971.ref094]\]. However, serious AEs can occur as a result of BSA and BVA in patients with positive skins tests. There is a report of a young, healthy adult who was sensitized to bee venom through BSA, and who was later stung by a bee and developed severe, life-threatening anaphylaxis \[[@pone.0126971.ref161]\].

Venom concentration and the frequency of venom administration can influence the severity and rate of incidence of AEs resulting from BSA and BVA. Unfortunately, we could not analyze the effect of venom concentration and administration frequency on the severity and rate of incidence of AEs because only limited numbers of RCTs were included in this review.

With regard to the quality of reporting of AEs in RCTs, CONSORT items were generally not reported properly. Future RCTs with BVT must adopt the CONSORT AE reporting guidelines to ensure transparency and accuracy. When designing protocols, methods of AE assessment based on the CONSORT AE reporting guidelines should be suggested in detail.

AEs related to BVA or VIT have been reported in various studies, including surveys \[[@pone.0126971.ref008]\] \[[@pone.0126971.ref162]\] \[[@pone.0126971.ref163]\] and reviews \[[@pone.0126971.ref159]\] \[[@pone.0126971.ref160]\] \[[@pone.0126971.ref164]\] \[[@pone.0126971.ref165]\]. However, in this paper, we extensively reviewed all types of BVT (BSA, BVA, SBV, apitoxin injection, and VIT). We focused on the incidence of AEs in audit and cohort studies related to BVT, and sought to provide an overview of the many types of AEs that were reported in case studies and case series. We performed this investigation through a comprehensive search of the literature.

This review has some limitations. First, the heterogeneity of intervention in the reviewed articles was high; thus, the exact AE incidence and risk associated with the treatment methods could not be calculated. Second, although different venoms were used in different therapies (bee \[family Apidae\] venom was mainly used in BSA and BVA, whereas venom of both bees \[family Apidae\] and wasps \[family Vespidae\] was used in VIT), AEs from VIT were not classified in terms of the type of venom, treatment protocol (conventional VIT, cluster VIT, rush VIT, ultra-rush VIT, etc.), or phase (induction and maintenance).

While it is evident that BVA clearly increases the risk of AEs in comparison with normal saline, our review revealed that BSA and BVA are often implemented without a skin test, and also showed that patients have experienced SAEs that can be fatal after receiving BSA from unqualified personnel. Therefore, in order to enhance the safety of BVT, a skin test should be conducted before BVT is administered, and the venom should be administered only by qualified individuals \[[@pone.0126971.ref166]\].

Based on the results of this review, several suggestions can be made to support effective clinical practice and future clinical trials with BVT. In order to support responsible use of BVT, educational materials on the safety and efficacy of BVT should be made available for patients. Moreover, practitioners should be aware of the various AEs associated with BVT, establish clinical guidelines to minimize the development of AEs, and develop and implement strict criteria for monitoring AEs once they occur.

Conclusion {#sec023}
==========

AEs related to BVT are not uncommon. Therefore, BVT practitioners should pay careful attention to the incidence of AEs and patterns of AE occurrence in their patients. Additionally, education and qualification of BVT practitioners should be ensured based on appropriate training programs and clinical guidelines for monitoring of AEs related to BVA and BSA. Furthermore, when reporting AEs in RCTs evaluating BVT, researchers should describe AEs in detail according to the CONSORT recommendation for harm data to ensure transparency and accuracy.
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